# Liver-Targeted siRNA Therapy Prevents Brain Damage in Glutaric Aciduria

> A preclinical study published in Science Translational Medicine reports that a liver-directed siRNA therapy prevented brain injury and rescued mouse models of glutaric aciduria type I. The research was led by Duke University with the University of Colorado Anschutz and Alnylam Pharmaceuticals.

- Date: 2026-11-21 · published 2026-11-21T09:12:10.708Z
- Category: report · region US · magnitude low
- Page: https://feedsoft.ai/events/112601-liver-targeted-sirna-therapy-prevents-brain-damage-in-glutaric-aciduria
- Commodities: [Lysine](https://feedsoft.ai/c/LYSINE.md)

## Why it matters

This is a human health and pharmaceutical development story with no link to feed grains, oilseeds, or livestock supply, so it does not plausibly move feed commodity supply, demand, or prices.

## Sources

- scienmag.com: https://scienmag.com/liver-targeted-sirna-therapy-prevents-brain-damage-in-glutaric-aciduria-mouse-models/

---
Data from Feedsoft AI (https://feedsoft.ai/). For information only; not investment advice.
